For the Inventor, By the Inventor

Enter assignee name

Chungcheongbuk-do, South Korea

Nano Intelligent Biomedical Engineering Corporation Co. Ltd.

USPTO Granted Patents = 19

EPO Patents = 15

Trademarks = 1

Forward Citations = 41

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Chong-Pyoung Chung (19 out of 27 patents)

Jue-Yeon Lee (17 out of 23 patents)

Yoon Jeong Park (12 out of 17 patents)

4. Yoon-Jeong Park (7 out of 9 patents)

5. Jin Sook Suh (7 out of 7 patents)

6. Yeonsu Kim (2 out of 40 patents)

7. Dong Woo Lee (2 out of 49 patents)

8. Joocheol Park (1 out of 1 patent)

9. In Ho Jo (1 out of 1 patent)

10. Yoon Jung Choi (1 out of 1 patent)

11. Gene Lee (1 out of 2 patents)

12. Hyun Kil Nam (1 out of 43 patents)

13. Sang Hoon Rhee (1 out of 2 patents)

14. Hyun Jung Park (1 out of 15 patents)

15. In Kyong Shim (1 out of 2 patents)

19 patents: Sort by Forward Citations

1. 11365218 - Bifunctional peptide having capability to reduce inflammation and capability to facilitate differentiation of stem cells into chondrocytes and use thereof (2022-06-21),

2. 11179445 - Pharmaceutical composition and biomaterial comprising fusion peptide in which bone tissue-selective peptide bound to parathyroid hormone (PTH) or fragment thereof (2021-11-23),

3. 10836795 - Dual functional novel peptide having cell permeability and bone tissue regeneration ability, and use thereof (2020-11-17),

4. 10815312 - Bifunctional peptide having capability to permeate cells and capability to regenerate muscles and use thereof (2020-10-27),

5. 10406264 - Peptide having titanium-binding ability (2019-09-10),

6. 10232083 - Mimetic tissue structure containing extracellular matrix protein-bone mineral complex and method for manufacturing same (2019-03-19),

7. 10155022 - Fat accumulation inhibitory peptide and pharmaceutical composition for preventing or treating obesity containing the same (2018-12-18),

8. 10066212 - Method for preparing induced pluripotent stem cells using synthetic peptide (2018-09-04),

9. 9993519 - Anticancer peptide for inhibiting proliferation of cancer stem cells and use thereof (2018-06-12),

10. 9849190 - Peptide having cancer selective translocation function and use thereof (2017-12-26),

11. 9801973 - Peptide having zirconia-binding capacity (2017-10-31),

12. 9644185 - Cell permeable fusion protein for facilitating reprogramming induction and use thereof (2017-05-09),

13. 9408920 - Cell-penetrating fusion protein for regenerating or proliferating stem cell (2016-08-09),

14. 9133246 - Surface-active collagen membrane by peptide (2015-09-15),

15. 9023987 - Cell-permeable peptide (2015-05-05),

Nano Intelligent Biomedical Engineering Corporation Co. Ltd. is a leading company in the field of biomedical engineering, specializing in the development and manufacturing of innovative nanotechnology-based healthcare solutions. With a focus on precision medicine and personalized healthcare, the company aims to revolutionize the way diseases are diagnosed and treated. Through cutting-edge research and collaboration with healthcare professionals, Nano Intelligent Biomedical Engineering Corporation Co. Ltd. is committed to improving patient outcomes and enhancing overall quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#6 in Chungcheongbuk-do

#629 in South Korea

#31,708 in the World

Chungcheongbuk-do, South Korea

Nano Intelligent Biomedical Engineering Corporation Co. Ltd.

Forward Citations = 41

17 inventors:

Chong-Pyoung Chung (19 out of 27 patents)

Jue-Yeon Lee (17 out of 23 patents)

Yoon Jeong Park (12 out of 17 patents)

4. Yoon-Jeong Park (7 out of 9 patents)

5. Jin Sook Suh (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…